Senseonics announced that it has received notice from the FDA that its Eversense sensor no longer has to be removed for MRI scanning.
“Based on our testing, we have demonstrated hat it is safe for patients to leave the Eversense Sensor in place, even when they need to have an MRI,” Tim Goodnow, president and CEO of Senseonics, said in a press release. “Now patients using Eversense CGM do not need to worry about an emergency MRI or delay getting a scheduled MRI based on their glucose sensor. All other CGMs currently on the market are required to be removed before an MRI scan, according to their FDA indications. This is a first for the CGM category.”
The post Senseonics wins MRI-safe FDA nod for Eversense CGM appeared first on MassDevice.